Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Epanutin

- PMLiVE

Eisai pulls epilepsy drug Fycompa in Germany

Based on unfavourable assessment by pricing body

UK flag

UK plans to cut some drug prices by up to 20 per cent

DH proposal relates to medicines not covered by PPRS

- PMLiVE

Healthwatch England appoints comms and policy directors

Claire Pimm joins from DH and Marc Bush joins from Scope

UK launch for Pfizer’s long-acting contraceptive injection Sayana

Becomes first contraceptive of its kind to reach the UK market

Synexus South Africa research sites join Pfizer trial network

CRO's sites become the first in Africa to meet the pharma company's standards

- PMLiVE

New formulations of Pralia and Enbrel head list of new drugs in Japan

Regulator backs medicines from Pfizer, Takeda, Daiichi Sankyo, Astellas, Zeria and otsuka

- PMLiVE

­Pfizer signs $635m deal with CytomX for cancer ADCs

Will use biotech's Probody technology to develop antibody-drug conjugates

- PMLiVE

GSK/ Valeant’s Trobalt set for EU restrictions

Eye concerns prompt CHMP to recommend last-line use for the epilepsy drug

- PMLiVE

England to launch 15 networks for NHS to work with academia

NHS England backs Academic Health Science Networks to spread innovation

- PMLiVE

Clare Gerada to step down as UK RCGP chair

Maureen Baker nominated as chair-elect

- PMLiVE

David Nicholson to step down as head of England’s NHS

Decision to retire comes two months after publication of Francis report into hospital scandal

- PMLiVE

Novartis wins third NICE recommendation for Lucentis

Gains final backing to treat NHS patients with macular oedema

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links